|
Clinical Research Detail |
|
Title Of Study |
To Study the effect, safety, and tolerability of every 4 weekly administration of subcutaneous Mircera for treating renal anaemia in diabetic nephropathy patients
|
|
Disease Condition |
Type 2 diabetes mellitus; Chronic kidney disease stages III-IV not on dialysis, not currently treated with ESA.
|
|
Phase of Trial |
Phase-4
|
Discipline |
Diabetology
|
|
Start date of Trial |
8/27/2010
|
Closing Date of Trial |
8/27/2011
|
|
|